The global market for Acute Kidney Injury Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Acute Kidney Injury Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Kidney Injury Drugs.

The Acute Kidney Injury Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Acute Kidney Injury Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Acute Kidney Injury Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Acute Kidney Injury Drugs Market Report

Report Metric	Details
Report Name	Acute Kidney Injury Drugs Market
CAGR	5%
Segment by Type	Prerenal Acute Kidney Injury Postrenal Acute Kidney Injury Intrinsic Acute Kidney Injury Others
Segment by Application	Hospital Clinic
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Quark Pharmaceuticals, Baxter International, Fresenius Medical Care AG & Co. KGaA, LG Chem, Asahi Kasei Medical, B. Braun Melsungen AG, Angion Biomedica Corp
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Acute Kidney Injury Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Acute Kidney Injury Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Acute Kidney Injury Drugs Market report?

Ans: The main players in the Acute Kidney Injury Drugs Market are Quark Pharmaceuticals, Baxter International, Fresenius Medical Care AG & Co. KGaA, LG Chem, Asahi Kasei Medical, B. Braun Melsungen AG, Angion Biomedica Corp

What are the Application segmentation covered in the Acute Kidney Injury Drugs Market report?

Ans: The Applications covered in the Acute Kidney Injury Drugs Market report are Hospital, Clinic

What are the Type segmentation covered in the Acute Kidney Injury Drugs Market report?

Ans: The Types covered in the Acute Kidney Injury Drugs Market report are Prerenal Acute Kidney Injury, Postrenal Acute Kidney Injury, Intrinsic Acute Kidney Injury, Others

1 Acute Kidney Injury Drugs Market Overview

1.1 Product Definition

1.2 Acute Kidney Injury Drugs by Type

1.2.1 Global Acute Kidney Injury Drugs Market Value Comparison by Type (2024 VS 2031)

1.2.2 Prerenal Acute Kidney Injury

1.2.3 Postrenal Acute Kidney Injury

1.2.4 Intrinsic Acute Kidney Injury

1.2.5 Others

1.3 Acute Kidney Injury Drugs by Application

1.3.1 Global Acute Kidney Injury Drugs Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.4 Global Acute Kidney Injury Drugs Market Size Estimates and Forecasts

1.4.1 Global Acute Kidney Injury Drugs Revenue 2020-2031

1.4.2 Global Acute Kidney Injury Drugs Sales 2020-2031

1.4.3 Global Acute Kidney Injury Drugs Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Acute Kidney Injury Drugs Market Competition by Manufacturers

2.1 Global Acute Kidney Injury Drugs Sales Market Share by Manufacturers (2020-2025)

2.2 Global Acute Kidney Injury Drugs Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Acute Kidney Injury Drugs Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Acute Kidney Injury Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Acute Kidney Injury Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Acute Kidney Injury Drugs, Product Type & Application

2.7 Global Key Manufacturers of Acute Kidney Injury Drugs, Date of Enter into This Industry

2.8 Global Acute Kidney Injury Drugs Market Competitive Situation and Trends

2.8.1 Global Acute Kidney Injury Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Acute Kidney Injury Drugs Players Market Share by Revenue

2.8.3 Global Acute Kidney Injury Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Acute Kidney Injury Drugs Market Scenario by Region

3.1 Global Acute Kidney Injury Drugs Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Acute Kidney Injury Drugs Sales by Region: 2020-2031

3.2.1 Global Acute Kidney Injury Drugs Sales by Region: 2020-2025

3.2.2 Global Acute Kidney Injury Drugs Sales by Region: 2026-2031

3.3 Global Acute Kidney Injury Drugs Revenue by Region: 2020-2031

3.3.1 Global Acute Kidney Injury Drugs Revenue by Region: 2020-2025

3.3.2 Global Acute Kidney Injury Drugs Revenue by Region: 2026-2031

3.4 North America Acute Kidney Injury Drugs Market Facts & Figures by Country

3.4.1 North America Acute Kidney Injury Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Acute Kidney Injury Drugs Sales by Country (2020-2031)

3.4.3 North America Acute Kidney Injury Drugs Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Acute Kidney Injury Drugs Market Facts & Figures by Country

3.5.1 Europe Acute Kidney Injury Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Acute Kidney Injury Drugs Sales by Country (2020-2031)

3.5.3 Europe Acute Kidney Injury Drugs Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Acute Kidney Injury Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Acute Kidney Injury Drugs Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Acute Kidney Injury Drugs Sales by Region (2020-2031)

3.6.3 Asia Pacific Acute Kidney Injury Drugs Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Acute Kidney Injury Drugs Market Facts & Figures by Country

3.7.1 Latin America Acute Kidney Injury Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Acute Kidney Injury Drugs Sales by Country (2020-2031)

3.7.3 Latin America Acute Kidney Injury Drugs Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Acute Kidney Injury Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Acute Kidney Injury Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Acute Kidney Injury Drugs Sales by Country (2020-2031)

3.8.3 Middle East and Africa Acute Kidney Injury Drugs Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Acute Kidney Injury Drugs Sales by Type (2020-2031)

4.1.1 Global Acute Kidney Injury Drugs Sales by Type (2020-2025)

4.1.2 Global Acute Kidney Injury Drugs Sales by Type (2026-2031)

4.1.3 Global Acute Kidney Injury Drugs Sales Market Share by Type (2020-2031)

4.2 Global Acute Kidney Injury Drugs Revenue by Type (2020-2031)

4.2.1 Global Acute Kidney Injury Drugs Revenue by Type (2020-2025)

4.2.2 Global Acute Kidney Injury Drugs Revenue by Type (2026-2031)

4.2.3 Global Acute Kidney Injury Drugs Revenue Market Share by Type (2020-2031)

4.3 Global Acute Kidney Injury Drugs Price by Type (2020-2031)

5 Segment by Application

5.1 Global Acute Kidney Injury Drugs Sales by Application (2020-2031)

5.1.1 Global Acute Kidney Injury Drugs Sales by Application (2020-2025)

5.1.2 Global Acute Kidney Injury Drugs Sales by Application (2026-2031)

5.1.3 Global Acute Kidney Injury Drugs Sales Market Share by Application (2020-2031)

5.2 Global Acute Kidney Injury Drugs Revenue by Application (2020-2031)

5.2.1 Global Acute Kidney Injury Drugs Revenue by Application (2020-2025)

5.2.2 Global Acute Kidney Injury Drugs Revenue by Application (2026-2031)

5.2.3 Global Acute Kidney Injury Drugs Revenue Market Share by Application (2020-2031)

5.3 Global Acute Kidney Injury Drugs Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Quark Pharmaceuticals

6.1.1 Quark Pharmaceuticals Company Information

6.1.2 Quark Pharmaceuticals Description and Business Overview

6.1.3 Quark Pharmaceuticals Acute Kidney Injury Drugs Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Quark Pharmaceuticals Acute Kidney Injury Drugs Product Portfolio

6.1.5 Quark Pharmaceuticals Recent Developments/Updates

6.2 Baxter International

6.2.1 Baxter International Company Information

6.2.2 Baxter International Description and Business Overview

6.2.3 Baxter International Acute Kidney Injury Drugs Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Baxter International Acute Kidney Injury Drugs Product Portfolio

6.2.5 Baxter International Recent Developments/Updates

6.3 Fresenius Medical Care AG & Co. KGaA

6.3.1 Fresenius Medical Care AG & Co. KGaA Company Information

6.3.2 Fresenius Medical Care AG & Co. KGaA Description and Business Overview

6.3.3 Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Drugs Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Drugs Product Portfolio

6.3.5 Fresenius Medical Care AG & Co. KGaA Recent Developments/Updates

6.4 LG Chem

6.4.1 LG Chem Company Information

6.4.2 LG Chem Description and Business Overview

6.4.3 LG Chem Acute Kidney Injury Drugs Sales, Revenue and Gross Margin (2020-2025)

6.4.4 LG Chem Acute Kidney Injury Drugs Product Portfolio

6.4.5 LG Chem Recent Developments/Updates

6.5 Asahi Kasei Medical

6.5.1 Asahi Kasei Medical Company Information

6.5.2 Asahi Kasei Medical Description and Business Overview

6.5.3 Asahi Kasei Medical Acute Kidney Injury Drugs Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Asahi Kasei Medical Acute Kidney Injury Drugs Product Portfolio

6.5.5 Asahi Kasei Medical Recent Developments/Updates

6.6 B. Braun Melsungen AG

6.6.1 B. Braun Melsungen AG Company Information

6.6.2 B. Braun Melsungen AG Description and Business Overview

6.6.3 B. Braun Melsungen AG Acute Kidney Injury Drugs Sales, Revenue and Gross Margin (2020-2025)

6.6.4 B. Braun Melsungen AG Acute Kidney Injury Drugs Product Portfolio

6.6.5 B. Braun Melsungen AG Recent Developments/Updates

6.7 Angion Biomedica Corp

6.7.1 Angion Biomedica Corp Company Information

6.7.2 Angion Biomedica Corp Description and Business Overview

6.7.3 Angion Biomedica Corp Acute Kidney Injury Drugs Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Angion Biomedica Corp Acute Kidney Injury Drugs Product Portfolio

6.7.5 Angion Biomedica Corp Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Acute Kidney Injury Drugs Industry Chain Analysis

7.2 Acute Kidney Injury Drugs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Acute Kidney Injury Drugs Production Mode & Process Analysis

7.4 Acute Kidney Injury Drugs Sales and Marketing

7.4.1 Acute Kidney Injury Drugs Sales Channels

7.4.2 Acute Kidney Injury Drugs Distributors

7.5 Acute Kidney Injury Drugs Customer Analysis

8 Acute Kidney Injury Drugs Market Dynamics

8.1 Acute Kidney Injury Drugs Industry Trends

8.2 Acute Kidney Injury Drugs Market Drivers

8.3 Acute Kidney Injury Drugs Market Challenges

8.4 Acute Kidney Injury Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Quark Pharmaceuticals

Baxter International

Fresenius Medical Care Ag& Co. Kgaa

LG Chem

Asahi Kasei Medical

B Braun Melsungen AG

Angion Biomedica Corp

List of Tables

Table 1. Global Acute Kidney Injury Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Acute Kidney Injury Drugs Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Acute Kidney Injury Drugs Market Competitive Situation by Manufacturers in 2024

Table 4. Global Acute Kidney Injury Drugs Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Acute Kidney Injury Drugs Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Acute Kidney Injury Drugs Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Acute Kidney Injury Drugs Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Acute Kidney Injury Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Acute Kidney Injury Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Acute Kidney Injury Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Acute Kidney Injury Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Acute Kidney Injury Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Acute Kidney Injury Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Kidney Injury Drugs as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Acute Kidney Injury Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Acute Kidney Injury Drugs Sales by Region (2020-2025) & (K Units)

Table 18. Global Acute Kidney Injury Drugs Sales Market Share by Region (2020-2025)

Table 19. Global Acute Kidney Injury Drugs Sales by Region (2026-2031) & (K Units)

Table 20. Global Acute Kidney Injury Drugs Sales Market Share by Region (2026-2031)

Table 21. Global Acute Kidney Injury Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Acute Kidney Injury Drugs Revenue Market Share by Region (2020-2025)

Table 23. Global Acute Kidney Injury Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Acute Kidney Injury Drugs Revenue Market Share by Region (2026-2031)

Table 25. North America Acute Kidney Injury Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Acute Kidney Injury Drugs Sales by Country (2020-2025) & (K Units)

Table 27. North America Acute Kidney Injury Drugs Sales by Country (2026-2031) & (K Units)

Table 28. North America Acute Kidney Injury Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Acute Kidney Injury Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Acute Kidney Injury Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Acute Kidney Injury Drugs Sales by Country (2020-2025) & (K Units)

Table 32. Europe Acute Kidney Injury Drugs Sales by Country (2026-2031) & (K Units)

Table 33. Europe Acute Kidney Injury Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Acute Kidney Injury Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Acute Kidney Injury Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Acute Kidney Injury Drugs Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Acute Kidney Injury Drugs Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Acute Kidney Injury Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Acute Kidney Injury Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Acute Kidney Injury Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Acute Kidney Injury Drugs Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Acute Kidney Injury Drugs Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Acute Kidney Injury Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Acute Kidney Injury Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Acute Kidney Injury Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Acute Kidney Injury Drugs Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Acute Kidney Injury Drugs Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Acute Kidney Injury Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Acute Kidney Injury Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Acute Kidney Injury Drugs Sales (K Units) by Type (2020-2025)

Table 51. Global Acute Kidney Injury Drugs Sales (K Units) by Type (2026-2031)

Table 52. Global Acute Kidney Injury Drugs Sales Market Share by Type (2020-2025)

Table 53. Global Acute Kidney Injury Drugs Sales Market Share by Type (2026-2031)

Table 54. Global Acute Kidney Injury Drugs Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Acute Kidney Injury Drugs Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Acute Kidney Injury Drugs Revenue Market Share by Type (2020-2025)

Table 57. Global Acute Kidney Injury Drugs Revenue Market Share by Type (2026-2031)

Table 58. Global Acute Kidney Injury Drugs Price (US$/Unit) by Type (2020-2025)

Table 59. Global Acute Kidney Injury Drugs Price (US$/Unit) by Type (2026-2031)

Table 60. Global Acute Kidney Injury Drugs Sales (K Units) by Application (2020-2025)

Table 61. Global Acute Kidney Injury Drugs Sales (K Units) by Application (2026-2031)

Table 62. Global Acute Kidney Injury Drugs Sales Market Share by Application (2020-2025)

Table 63. Global Acute Kidney Injury Drugs Sales Market Share by Application (2026-2031)

Table 64. Global Acute Kidney Injury Drugs Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Acute Kidney Injury Drugs Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Acute Kidney Injury Drugs Revenue Market Share by Application (2020-2025)

Table 67. Global Acute Kidney Injury Drugs Revenue Market Share by Application (2026-2031)

Table 68. Global Acute Kidney Injury Drugs Price (US$/Unit) by Application (2020-2025)

Table 69. Global Acute Kidney Injury Drugs Price (US$/Unit) by Application (2026-2031)

Table 70. Quark Pharmaceuticals Company Information

Table 71. Quark Pharmaceuticals Description and Business Overview

Table 72. Quark Pharmaceuticals Acute Kidney Injury Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Quark Pharmaceuticals Acute Kidney Injury Drugs Product

Table 74. Quark Pharmaceuticals Recent Developments/Updates

Table 75. Baxter International Company Information

Table 76. Baxter International Description and Business Overview

Table 77. Baxter International Acute Kidney Injury Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Baxter International Acute Kidney Injury Drugs Product

Table 79. Baxter International Recent Developments/Updates

Table 80. Fresenius Medical Care AG & Co. KGaA Company Information

Table 81. Fresenius Medical Care AG & Co. KGaA Description and Business Overview

Table 82. Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Drugs Product

Table 84. Fresenius Medical Care AG & Co. KGaA Recent Developments/Updates

Table 85. LG Chem Company Information

Table 86. LG Chem Description and Business Overview

Table 87. LG Chem Acute Kidney Injury Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. LG Chem Acute Kidney Injury Drugs Product

Table 89. LG Chem Recent Developments/Updates

Table 90. Asahi Kasei Medical Company Information

Table 91. Asahi Kasei Medical Description and Business Overview

Table 92. Asahi Kasei Medical Acute Kidney Injury Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Asahi Kasei Medical Acute Kidney Injury Drugs Product

Table 94. Asahi Kasei Medical Recent Developments/Updates

Table 95. B. Braun Melsungen AG Company Information

Table 96. B. Braun Melsungen AG Description and Business Overview

Table 97. B. Braun Melsungen AG Acute Kidney Injury Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. B. Braun Melsungen AG Acute Kidney Injury Drugs Product

Table 99. B. Braun Melsungen AG Recent Developments/Updates

Table 100. Angion Biomedica Corp Company Information

Table 101. Angion Biomedica Corp Description and Business Overview

Table 102. Angion Biomedica Corp Acute Kidney Injury Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Angion Biomedica Corp Acute Kidney Injury Drugs Product

Table 104. Angion Biomedica Corp Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. Acute Kidney Injury Drugs Distributors List

Table 108. Acute Kidney Injury Drugs Customers List

Table 109. Acute Kidney Injury Drugs Market Trends

Table 110. Acute Kidney Injury Drugs Market Drivers

Table 111. Acute Kidney Injury Drugs Market Challenges

Table 112. Acute Kidney Injury Drugs Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Product Picture of Acute Kidney Injury Drugs

Figure 2. Global Acute Kidney Injury Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Acute Kidney Injury Drugs Market Share by Type: 2024 & 2031

Figure 4. Prerenal Acute Kidney Injury Product Picture

Figure 5. Postrenal Acute Kidney Injury Product Picture

Figure 6. Intrinsic Acute Kidney Injury Product Picture

Figure 7. Others Product Picture

Figure 8. Global Acute Kidney Injury Drugs Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Acute Kidney Injury Drugs Market Share by Application: 2024 & 2031

Figure 10. Hospital

Figure 11. Clinic

Figure 12. Global Acute Kidney Injury Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Acute Kidney Injury Drugs Market Size (2020-2031) & (US$ Million)

Figure 14. Global Acute Kidney Injury Drugs Sales (2020-2031) & (K Units)

Figure 15. Global Acute Kidney Injury Drugs Average Price (US$/Unit) & (2020-2031)

Figure 16. Acute Kidney Injury Drugs Report Years Considered

Figure 17. Acute Kidney Injury Drugs Sales Share by Manufacturers in 2024

Figure 18. Global Acute Kidney Injury Drugs Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Acute Kidney Injury Drugs Players: Market Share by Revenue in Acute Kidney Injury Drugs in 2024

Figure 20. Acute Kidney Injury Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Acute Kidney Injury Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Acute Kidney Injury Drugs Sales Market Share by Country (2020-2031)

Figure 23. North America Acute Kidney Injury Drugs Revenue Market Share by Country (2020-2031)

Figure 24. United States Acute Kidney Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Acute Kidney Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Acute Kidney Injury Drugs Sales Market Share by Country (2020-2031)

Figure 27. Europe Acute Kidney Injury Drugs Revenue Market Share by Country (2020-2031)

Figure 28. Germany Acute Kidney Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Acute Kidney Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Acute Kidney Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Acute Kidney Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Acute Kidney Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Acute Kidney Injury Drugs Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Acute Kidney Injury Drugs Revenue Market Share by Region (2020-2031)

Figure 35. China Acute Kidney Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Acute Kidney Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Acute Kidney Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Acute Kidney Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Acute Kidney Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Acute Kidney Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Acute Kidney Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Acute Kidney Injury Drugs Sales Market Share by Country (2020-2031)

Figure 43. Latin America Acute Kidney Injury Drugs Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Acute Kidney Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Acute Kidney Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Acute Kidney Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Acute Kidney Injury Drugs Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Acute Kidney Injury Drugs Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Acute Kidney Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Acute Kidney Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Acute Kidney Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Acute Kidney Injury Drugs by Type (2020-2031)

Figure 53. Global Revenue Market Share of Acute Kidney Injury Drugs by Type (2020-2031)

Figure 54. Global Acute Kidney Injury Drugs Price (US$/Unit) by Type (2020-2031)

Figure 55. Global Sales Market Share of Acute Kidney Injury Drugs by Application (2020-2031)

Figure 56. Global Revenue Market Share of Acute Kidney Injury Drugs by Application (2020-2031)

Figure 57. Global Acute Kidney Injury Drugs Price (US$/Unit) by Application (2020-2031)

Figure 58. Acute Kidney Injury Drugs Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Kidney Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Acute Lung Injury Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Renal Disease Treatment Market Research Report 2024

Global Drug induced Nephrotoxicity Treatment Market Research Report 2025

Global Chronic Kidney Disease Drugs Market Research Report 2025

Kidney Fibrosis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Urinary Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Kidney Cancer Targeted Therapy Market Research Report 2025

Global Kidney Cancer Diagnosis Market Research Report 2025

Global Continuous Renal Replacement Therapy Market Research Report 2024

Rare Kidney Diseases Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Acquired Cystic Kidney Disease Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Complement Drug for Kidney Disease Market Research Report 2024

Urinary System Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Urinary Tract Infection Therapeutics Market Research Report 2025

Acute Kidney Injury Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Emergency Care Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Renal Anemia Therapeutics Market Research Report 2025

Renal Cyst Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

120 Pages

Type: Report

Code: QYRE-Auto-2J9266

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Embolization Particle Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-33P8693

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Ampicillin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-9P9060

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Autism Spectrum Disorder Educational Software Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-18B19448

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Acute Kidney Injury Drugs Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-20O13353

Global Acute Kidney Injury Drugs Market Research Report 2025

FEATURED COMPANIES

Acute Kidney Injury Drugs Market Size

Acute Kidney Injury Drugs Market

Report Scope

Scope of Acute Kidney Injury Drugs Market Report

Core Chapters

FAQ for this report

Who are the main players in the Acute Kidney Injury Drugs Market report?

What are the Application segmentation covered in the Acute Kidney Injury Drugs Market report?

What are the Type segmentation covered in the Acute Kidney Injury Drugs Market report?

FEATURED COMPANIES

RELATED REPORTS